PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of California, San Francisco
About this trial
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
Eligibility criteria
Qualifiers
Age 18 years or greater
Undergoing evaluation for a newly diagnosed gynecologic malignancy
Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
Disqualifiers
Contraindication to any study-related procedure or assessment
Does not speak a language for which the consent form and study materials are available
Trial design
Treatments tested in this trial
- Physical function assessment
- Self-reported Assessments and Questionnaires
- Surgery (Standard of Care, Non-Interventional)
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
University of California, San Francisco
Lead sponsor
Conquer Cancer Foundation
Collaborator
American Society of Clinical Oncology
Collaborator
National Institute on Aging (NIA)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Source ClinicalTrials.gov